USPTO serial 79025462
Serial No. 79025462
Reviewed by CopyMark Law Group
Reg. 3275461Status 404
- Filing date
- Status date
- Registration date
- Aug 7, 2007
- Examiner
- YAO, GRETTA
- Law office
- POST REGISTRATION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with Serial No. 79025462?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical, veterinary preparations for liver diseases, renal disease, nerve system diseases, skin diseases, cardiovascular diseases, cancer and sanitary preparations for medical use; central nervous system stimulants; hair growth stimulant; antipyretic analgesics; anti-epileptics; analeptics; hypnotic sedatives; general anesthetics; anti-motion sickness preparations; pharmaceutical preparations acting on the peripheral nervous system; local anesthetics; skeletal muscle relaxants; anhidrotics; autonomics; antispasmodics; diaphoretics; pharmaceutical preparations acting on the sensory organs; ophthalmic preparations; agents for optic and nasal use, namely, nasal spray preparations, eye washes, eye drops, irrigating solutions for eye use; treatment for eye infection, macular degeneration, retinopathy, rhinitis, sinusitis; pharmaceutical antiallergic preparations; antihistaminics; cardiovascular treatment preparations; cardiotonics; antihypertensives; vasoconstrictors; capillary stabilizers; cerebral hemorrhage prophylactic preparations; antiarrhythmic preparations; diuretics; pharmaceutical preparations acting on respiratory organs; respiratory stimulants; anti-cough drops; antitussive expectorants; pharmaceutical preparations acting on digestive organs; gastrointestinal cleaning agents; clysters; evacuants (purgatives); stomachics and digestives; pharmaceutical preparations for oral use, for oral inflammation; emetics; pharmaceutical preparations for dental purposes for gingivostomatitis, alveolar abscess, alveoloclasia; antacids; antiemetics; castor oil for medical purposes; cholagogues; hormones for medical purposes; thyroid and para-thyroid hormone preparations; mixed hormone preparations; estrogen preparations; pancreas hormone preparations; salivary gland hormone preparations; androgen preparations; pituitary hormone preparations; adrenal hormone preparations; pharmaceutical preparations acting on uro-genital and anal organs; oxytocics; anti-hemorrhoidals; emmenagogues; contraceptives; medicated skincare preparations; pharmaceutical preparations for purulence; anti-dermoinfectives; antimicrobials for dermatologic use; astringents; anti-inflammatory agents; analgesics; anti-itchings; talcum powder; medicated baby oils; medicated baby powders; medicated bath preparations; vitamin preparations; cod-liver oil drops; mixed vitamin preparations; vitamin A preparations; vitamin C preparations; vitamin D preparations; vitamin B preparations; multi-vitamin preparations; amino acid preparations for medical purposes; threonine preparations; tryptophane preparations; methionine preparations; lysine preparations; royal jelly for medical purposes; calcium supplements; chondroitin preparations; protein and amino acid preparations for medical purposes; saccharide preparations for treating skin diseases, namely, skin ulcer, injury, burn, scleroderma, dematitis, erythroderma, keratosis, dyschromatosis, lupus erhthematosus; mineral preparations for medical use; anticoagulants; blood substitutes for human and veterinary use; blood plasma; hemostatics; pharmaceutical preparations affecting metabolism; antidotes; enzyme preparations for medical purposes; lactagogues; lipotropic factor preparations; pharmaceutical preparations for the treatment of habitual intoxication; pharmaceutical preparations for activating cellular function; tumor suppressing agents; anti-cancer preparations; anti-sarcoma preparations; pharmaceutical preparations for treating physically caused lesions; pharmaceutical preparations for treating heatstroke; radiation sickness treating drugs; pharmaceutical preparations for treating chemically caused disorders, namely, chemical burn, side effect of anticancer drugs, immunosuppresants; [ chiorine ] * CHLORINE * -detoxication preparations; arsenic-detoxication preparations; benzol-detoxication preparations; antibiotic preparations; erythromycin preparations; chloramphenicol preparations; colistin-polymixin preparations; salkomycin preparations; streptomycin preparations; thiolutin preparations; tetracycline preparations; trichomycin preparations; mixed antibiotic preparations; penicillin preparations; chemotherapeutics; antisyphilitics; antituberculous preparations; sulfonamide preparations; antileprotic preparations; biological preparations for medical purposes; antitoxic sera; antitoxins; mixed biological preparations for medical purposes; preparations for biological tests for medical purposes; toxoids; vaccines; preparations for destroying parasites; anthelmintics; odor neutralizing preparations for use on drugs; pharmaceutical excipients; diagnostic preparations for medical use; X-ray contrast agents; diagnostic reagents for medical use; diagnostic media for bacteriological cultures for medical use; radio isotope markers for therapeutic or diagnostic use; opium alkaloid preparations; synthetic narcotics; coca alkaloid preparations; mosquito-repellent incenses; germicides and fungicides; rodenticides; insecticides; fumigants; herbicides, namely, weedkillers; insect-repellents; antiseptics | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 2, 2016 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | — |
| Jun 2, 2016 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Oct 9, 2015 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 20, 2015 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Apr 22, 2015 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Apr 22, 2015 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Nov 14, 2014 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Mar 14, 2014 | C71T | CANCELLED SECTION 71 | — |
| Jan 13, 2010 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 31, 2009 | A7OK | AMENDMENT UNDER SECTION 7 - PROCESSED | — |
| Dec 19, 2008 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 14, 2008 | PLGL | ASSIGNED TO PARALEGAL | — |
| Jan 29, 2008 | ES7R | TEAS SECTION 7 REQUEST RECEIVED | — |
| Dec 2, 2007 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 2, 2007 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Nov 19, 2007 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 7, 2007 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 22, 2007 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 2, 2007 | NPUB | NOTICE OF PUBLICATION | — |
| Mar 21, 2007 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Mar 19, 2007 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 16, 2007 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Mar 16, 2007 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 16, 2007 | ALIE | ASSIGNED TO LIE | — |
| Feb 7, 2007 | PAPER RECEIVED | — | |
| Nov 22, 2006 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 6, 2006 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 18, 2006 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 18, 2006 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 14, 2006 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 13, 2006 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 22, 2006 | RFWR | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW | — |
| Aug 17, 2006 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 16, 2006 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 3, 2006 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 3, 2006 | NWAP | NEW APPLICATION ENTERED | — |
| Aug 3, 2006 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |